Teva Pharmaceutical Industries Ltd

詳細情報 Teva Pharmaceutical Industries Ltd 企業名

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

企業情報

企業コードTEVA

会社名Teva Pharmaceutical Industries Ltd

上場日Jan 01, 1951

設立日1944

最高経営責任者「CEO」Mr. Richard D. Francis

従業員数33892

証券種類Ordinary Share

決算期末Jan 01

本社所在地124 Dvora Hanevi'a St.

都市TEL AVIV-YAFO

証券取引所Tel Aviv Stock Exchange

国Israel

郵便番号6944020

電話番号97239148213

ウェブサイトhttps://www.tevapharm.com/

企業コードTEVA

上場日Jan 01, 1951

設立日1944

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

地域別USD

会社名

収益

比率

United States

8.03B

48.56%

Europe

5.10B

30.85%

International Markets

2.46B

14.89%

Other

944.00M

5.71%

事業別

地域別

事業別USD

会社名

収益

比率

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

株主

更新時刻: Sat, May 17

株主統計

種類

株主統計

比率

Fidelity Management & Research Company LLC

6.57%

Ion Asset Management Israel Ltd

3.40%

Clal Insurance Enterprises Holdings Ltd.

3.30%

BlackRock Institutional Trust Company, N.A.

2.88%

Menora Mivtachim Insurance Ltd.

2.55%

Other

81.31%

株主統計

比率

Fidelity Management & Research Company LLC

6.57%

Ion Asset Management Israel Ltd

3.40%

Clal Insurance Enterprises Holdings Ltd.

3.30%

BlackRock Institutional Trust Company, N.A.

2.88%

Menora Mivtachim Insurance Ltd.

2.55%

Other

81.31%

種類

株主統計

比率

Investment Advisor

27.44%

Hedge Fund

13.25%

Investment Advisor/Hedge Fund

11.80%

Insurance Company

4.85%

Research Firm

2.85%

Pension Fund

1.63%

Family Office

1.32%

Bank and Trust

0.83%

Sovereign Wealth Fund

0.25%

Other

35.78%

機関投資家保有株

更新時刻: Mon, Jan 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1095

724.51M

63.17%

+11.84M

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

2023Q1

927

576.84M

51.93%

-50.26M

2022Q4

946

573.39M

51.61%

-69.40M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Fidelity Management & Research Company LLC

76.01M

6.63%

+14.91M

+24.41%

Dec 31, 2024

Ion Asset Management Israel Ltd

36.65M

3.2%

+409.78K

+1.13%

Dec 31, 2024

Clal Insurance Enterprises Holdings Ltd.

38.96M

3.4%

+4.42M

+12.79%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

33.10M

2.89%

+786.74K

+2.43%

Dec 31, 2024

Menora Mivtachim Insurance Ltd.

28.38M

2.48%

-456.80K

-1.58%

Dec 31, 2024

Lingotto Investment Management LLP

27.19M

2.37%

+688.86K

+2.60%

Dec 31, 2024

Phoenix Investment and Finances Ltd

21.21M

1.85%

-1.35M

-5.98%

Dec 31, 2024

Migdal Insurance and Financial Holdings Ltd

26.04M

2.27%

+569.41K

+2.24%

Dec 31, 2024

Rubric Capital Management LP

17.00M

1.48%

+994.50K

+6.21%

Dec 31, 2024

詳細を見る

17.005USD

Teva Pharmaceutical Industries Ltd

17.005

概要

企業名